Trialect

+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Not Verified

Expired

Liver Disease Research

Gilead Sciences

Program Overview

The Global Liver Disease program joins 3 previously separate regional programs. Three awardees will be selected in total. One award will be allocated to the US & Canada region, one to Europe / Australia and one award to the eligible Asian countries. Applicants from each of these regions will be reviewed by their respective Scientific Review Committee only.

Each awardee is funded up to $130,000 USD over two years, paid as annual installments of $65,000 USD per year directly to the scholar’s institution. Funding for the second year is contingent upon submission of a progress report and approval by the Chair of the Scientific Review Committee which oversees each regional program.

Recipients of these competitive awards under the program will be selected by a Committee comprised of leaders in the field of liver disease. The Committee will review complete applications and select research proposals based on their scientific merit, feasibility, and innovation. Announcement of Award Recipients will be made at an awards dinner hosted by the Committee and senior representatives from Gilead.

Specialties

Gastroenterology

Aesthetic and Cosmetic Surgery

Eligibility Requirements

Applicants must meet the following requirements:

Hold an MD, PhD, or equivalent degree at time of award
Anticipate receiving a faculty appointment (or a faculty position equivalent to an assistant professorship) within 3 years, in association with a research institution in one of the eligible countries
Have a strong career interest in liver disease
Have a research mentor with extensive experience in the field of liver disease
Be able to devote approximately 50% of professional time to research for the next 2 years (versus administrative, patient care, or teaching responsibilities)
Be able to complete the proposed research within the 2-year award period, providing evidence (manuscript, presentation, or abstracts) resulting from the research

Gilead’s Research Scholars Program is committed to building a more diverse and inclusive scientific community. Award selections are made without discrimination based on ethnicity, race, religion, national origin, gender, age, sexual orientation, physical or mental disability, genetic information or characteristic, gender identity and expression.

Citizenship

The Research Scholars Program in Liver Disease is open to emerging investigators from the US, Canada, Europe, Australia and certain Asian countries. For a full list of eligible countries please click here.

An applicant must be a citizen or permanent resident of one of the eligible countries or subject to the requirements noted below with regards to temporary visa/work permits. This visa must be valid for the duration of the award period or the applicant must be able to demonstrate that they are eligible for an extension, renewal or other status that will enable the applicant to undertake the research for the entirety of the two-year award.

Eligible Countries:

Sponsor Details

Sponsor Institute/Organizations: Gilead Sciences

Sponsor Type:

Address: 333 Lakeside Drive; Foster City, CA 94404;United States

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity